Viewing Study NCT03233477



Ignite Creation Date: 2024-05-06 @ 10:22 AM
Last Modification Date: 2024-10-26 @ 12:28 PM
Study NCT ID: NCT03233477
Status: UNKNOWN
Last Update Posted: 2020-10-14
First Post: 2017-07-22

Brief Title: Patient Registry of Posner-Schlossman Syndrome
Sponsor: Peking University
Organization: Peking University

Study Overview

Official Title: Patient Registry of Posner-Schlossman Syndrome
Status: UNKNOWN
Status Verified Date: 2020-10
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Posner-Schlossman syndrome or glaucomatocyclitic crisis is a condition characterized by recurrent acute attacks of mild nongranulomatous anterior uveitis accompanied by markedly elevated intraocular pressure Most of patients are the 20 to 50-year-old young adults with unilateral eye involvement PSS was originally deemed benign but is now recognized as a relatively rare cause of chronic secondary glaucomaespecially in patients with recurrent episodes This relatively rare disease is likely the result of the infections of a variety of organisms and the bulk of literature supports the cytomegalovirus CMV as the leading cause

This study is an observational study that does not interfere with the normal clinical diagnosis and treatment process The investigators in this study focus on observing the clinical symptoms and outcome of PSS analyzing the factors that affect the prognosis of PSS studying the association of its pathogenesis with the psychological status and the behavioral types of PSS patients exploring the relationship between infection CMV HSV Hp and PSS and studying the changes of local and systemic cytokine expression and its significance in patients with PSS
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None